Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries LA Jolla Pharma (NQ: LJPC ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Aug 19, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open - Bid (Size) 4.000 (1) Ask (Size) 6.250 (9) Prev. Close 6.220 Today's Range N/A - N/A 52wk Range N/A - N/A Shares Outstanding 24,936,883 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Innoviva Completes Acquisition of La Jolla Pharmaceutical August 22, 2022 From Innoviva, Inc. Via Business Wire LJPC Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of La Jolla Pharmaceutical Company Is Fair to Shareholders July 28, 2022 From Halper Sadeh LLP Via Business Wire Performance More News Read More LA JOLLA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of La Jolla Pharmaceutical Company - LJPC July 11, 2022 From Kahn Swick & Foti, LLC Via Business Wire Alibaba, Zoom Video And 76 Biggest Movers From Yesterday July 12, 2022 Via Benzinga Dow Dips Around 90 Points; La Jolla Pharmaceutical Shares Surge July 11, 2022 Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session July 11, 2022 Via Benzinga Nasdaq Tumbles 2%; Pliant Therapeutics Shares Spike Higher July 11, 2022 Via Benzinga Why These Casino Stocks Are Moving Lower, Here's 45 Stocks Moving In Monday's Mid-Day Session July 11, 2022 Via Benzinga 5 Top Short Squeeze Stocks to Watch This Week July 11, 2022 Via InvestorPlace La Jolla Pharmaceutical (LJPC) Stock Skyrockets on Innoviva Acquisition News July 11, 2022 Via InvestorPlace Why U.S. Stocks Are Trading Lower; AZZ Earnings And More July 11, 2022 Via Benzinga The Daily Biotech Pulse: Europe Approves Second Round Of Booster Doses of mRNA COVID-19 Vaccines, Perrigo Seeks Approval For First OTC Birth Control Pill, MacroGenics Closes Head & Cancer Study After Patient Death July 11, 2022 Via Benzinga LJPC Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of La Jolla Pharmaceutical Company Is Fair to Shareholders July 11, 2022 From Halper Sadeh LLP Via Business Wire 12 Health Care Stocks Moving In Monday's Pre-Market Session July 11, 2022 Via Benzinga Innoviva Bolsters Its Infectious Disease, Hospital Portfolio With La Jolla Deal July 11, 2022 Via Benzinga Innoviva to Acquire La Jolla Pharmaceutical Company July 11, 2022 From La Jolla Pharmaceutical Company Via Business Wire Recap: La Jolla Pharmaceutical Q1 Earnings May 16, 2022 Via Benzinga La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2022 and Highlights Corporate Progress May 16, 2022 From La Jolla Pharmaceutical Company Via Business Wire 5 Value Stocks To Watch In The Healthcare Sector March 21, 2022 Via Benzinga La Jolla Pharmaceutical Company Announces Share Repurchase Plan November 17, 2021 From La Jolla Pharmaceutical Company Via Business Wire 50 Biggest Movers From Yesterday November 30, 2021 Via Benzinga La Jolla Pharmaceutical Company Announces Financial Results for the Three and Nine Months Ended September 30, 2021 and Highlights Corporate Progress November 04, 2021 From La Jolla Pharmaceutical Company Via Business Wire Tony Hodges, M.D., FACP, FCCP, Appointed Chief Medical Officer of La Jolla Pharmaceutical Company September 10, 2021 From La Jolla Pharmaceutical Company Via Business Wire La Jolla Pharmaceutical Company Announces Financial Results for the Three and Six Months Ended June 30, 2021 and Highlights Corporate Progress August 05, 2021 From La Jolla Pharmaceutical Company Via Business Wire 99 Biggest Movers From Yesterday August 06, 2021 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.